509 related articles for article (PubMed ID: 22580654)
1. Terlipressin in the treatment of late phase catecholamine-resistant septic shock.
Svoboda P; Scheer P; Kantorová I; Doubek J; Dudra J; Radvan M; Radvanova J
Hepatogastroenterology; 2012 Jun; 59(116):1043-7. PubMed ID: 22580654
[TBL] [Abstract][Full Text] [Related]
2. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.
Morelli A; Ertmer C; Rehberg S; Lange M; Orecchioni A; Cecchini V; Bachetoni A; D'Alessandro M; Van Aken H; Pietropaoli P; Westphal M
Crit Care; 2009; 13(4):R130. PubMed ID: 19664253
[TBL] [Abstract][Full Text] [Related]
3. Terlipressin for norepinephrine-resistant septic shock.
O'Brien A; Clapp L; Singer M
Lancet; 2002 Apr; 359(9313):1209-10. PubMed ID: 11955542
[TBL] [Abstract][Full Text] [Related]
4. Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study.
Morelli A; Ertmer C; Lange M; Dünser M; Rehberg S; Van Aken H; Pietropaoli P; Westphal M
Br J Anaesth; 2008 Apr; 100(4):494-503. PubMed ID: 18308741
[TBL] [Abstract][Full Text] [Related]
5. Terlipressin facilitates transport of septic patients treated with norepinephrine.
Klein M; Weksler N; Borer A; Koyfman L; Kesslin J; Gurman GM
Isr Med Assoc J; 2006 Oct; 8(10):691-3. PubMed ID: 17125115
[TBL] [Abstract][Full Text] [Related]
6. Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock.
Morelli A; Ertmer C; Pietropaoli P; Westphal M
Expert Opin Pharmacother; 2009 Oct; 10(15):2569-75. PubMed ID: 19735216
[TBL] [Abstract][Full Text] [Related]
7. Terlipressin in catecholamine-resistant septic shock patients.
Leone M; Albanèse J; Delmas A; Chaabane W; Garnier F; Martin C
Shock; 2004 Oct; 22(4):314-9. PubMed ID: 15377885
[TBL] [Abstract][Full Text] [Related]
8. [A clinical study of pituitrin versus norepinephrine in the treatment of patients with septic shock].
Han XD; Sun H; Huang XY; Zhang SY; Wang YD; Ren K; Li F
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Jan; 24(1):33-7. PubMed ID: 22248749
[TBL] [Abstract][Full Text] [Related]
9. Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study.
Albanèse J; Leone M; Delmas A; Martin C
Crit Care Med; 2005 Sep; 33(9):1897-902. PubMed ID: 16148457
[TBL] [Abstract][Full Text] [Related]
10. [Vasodilatory septic shock refractory to catecholamines: is there a role for terlipressin?].
Fellahi JL; Bénard P; Daccache G; Mourgeon E; Gérard JL
Ann Fr Anesth Reanim; 2003 Jul; 22(7):631-4. PubMed ID: 12946495
[TBL] [Abstract][Full Text] [Related]
11. Terlipressin increased the concentration of L-lactate in the rectal lumen in a patient with septic shock.
Perner A; Jørgensen VL; Waldau T
Acta Anaesthesiol Scand; 2004 Sep; 48(8):1054-7. PubMed ID: 15315626
[TBL] [Abstract][Full Text] [Related]
12. Vasopressin and terlipressin in neonates and children with refractory septic shock.
Biban P; Gaffuri M
Curr Drug Metab; 2013 Feb; 14(2):186-92. PubMed ID: 23439212
[TBL] [Abstract][Full Text] [Related]
13. An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response.
Sharma P; Kumar A; Shrama BC; Sarin SK
Am J Gastroenterol; 2008 Jul; 103(7):1689-97. PubMed ID: 18557715
[TBL] [Abstract][Full Text] [Related]
14. Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials.
Serpa Neto A; Nassar AP; Cardoso SO; Manetta JA; Pereira VG; Espósito DC; Damasceno MC; Russell JA
Crit Care; 2012 Aug; 16(4):R154. PubMed ID: 22889256
[TBL] [Abstract][Full Text] [Related]
15. The role of terlipressin in pediatric septic shock: a review of the literature and personal experience.
Papoff P; Mancuso M; Barbara CS; Moretti C
Int J Immunopathol Pharmacol; 2007; 20(2):213-21. PubMed ID: 17624234
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial comparing terlipressin and noradrenaline in patients with cirrhosis and septic shock.
Choudhury A; Kedarisetty CK; Vashishtha C; Saini D; Kumar S; Maiwall R; Sharma MK; Bhadoria AS; Kumar G; Joshi YK; Sarin SK
Liver Int; 2017 Apr; 37(4):552-561. PubMed ID: 27633962
[TBL] [Abstract][Full Text] [Related]
17. Role of terlipressin in the treatment of infants and neonates with catecholamine-resistant septic shock.
Leone M; Martin C
Best Pract Res Clin Anaesthesiol; 2008 Jun; 22(2):323-33. PubMed ID: 18683478
[TBL] [Abstract][Full Text] [Related]
18. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis.
Avni T; Lador A; Lev S; Leibovici L; Paul M; Grossman A
PLoS One; 2015; 10(8):e0129305. PubMed ID: 26237037
[TBL] [Abstract][Full Text] [Related]
19. Terlipressin for catecholamine-resistant septic shock in children.
Rodríguez-Núñez A; Fernández-Sanmartín M; Martinón-Torres F; González-Alonso N; Martinón-Sánchez JM
Intensive Care Med; 2004 Mar; 30(3):477-80. PubMed ID: 14767584
[TBL] [Abstract][Full Text] [Related]
20. Vasopressor use in septic shock: an update.
Leone M; Martin C
Curr Opin Anaesthesiol; 2008 Apr; 21(2):141-7. PubMed ID: 18443479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
